HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respons...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
AboutScience Srl
2018-06-01
|
| سلاسل: | AboutOpen |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/160 |